# Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

> **NCT00297661** · PHASE4 · COMPLETED · sponsor: **University of Bern** · enrollment: 1012 (—)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DEVICE:** Sirolimus-eluting stent
- **DEVICE:** Paclitaxel-eluting stent

## Key facts

- **NCT ID:** NCT00297661
- **Lead sponsor:** University of Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1012 (—)
- **Last updated:** 2006-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297661, "Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00297661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*